Skip to main content

Find Clinical Trials

Home
Conditions
Melanoma

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,207 public trials 376 recruiting studies

Refine in advanced search Browse all conditions

Melanoma trial results

Recruiting

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

NCT06953089

Conditions: Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +42 more
Locations: USA06-0 Los Angeles, California, United States

USA16-0 Los Angeles, California, United States

USA01-0 Wheat Ridge, Colorado, United States

USA08-0 Florida City, Florida, United States

View all 37 locations

View Trial Details

Recruiting

Video Education With Result Dependent dIsclosure

NCT05225428

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +53 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

NCT04751396

Conditions: Ankylosing Spondylitis, Ankylosis, Arthritis, +56 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors

NCT07600476

Conditions: Basal Cell Carcinoma of Skin, Carcinoma, Carcinoma, Basal Cell, +18 more
Locations: Universitätsklinikum Würzburg Würzburg, Bavaria, Germany

Fachklinik Hornheide Münster, North Rhine-Westphalia, Germany

View Trial Details

Recruiting

Cryoablation+Ipilimumab+Nivolumab in Melanoma

NCT05779423

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +11 more
Locations: Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

View Trial Details

Recruiting

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

NCT04897321

Conditions: Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +65 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases

NCT06712927

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +16 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Recruiting

NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma

NCT06889766

Conditions: Advanced Melanoma, Melanoma, Melanoma Metastatic, +13 more
Locations: Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne, Canton of Vaud, Switzerland

Centre Hospitalier Universitaire Vaudois Lausanne, Canton of Vaud, Switzerland

View Trial Details

Recruiting

A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors

NCT07160335

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +32 more
Locations: Oncology Physicians Network (OPN) - Glendale Glendale, California, United States

Oncology Physicians Network (OPN)- Los Alamitos Los Alamitos, California, United States

HCA Los Angeles, California, United States

Los Angeles Cancer Network Los Angeles, California, United States

View all 69 locations

View Trial Details

Recruiting

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

NCT05379985

Conditions: Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +45 more
Locations: UC Irvine/Chao Family Comprehensive Cancer Center Orange, California, United States

UCLA Santa Monica, California, United States

Moffitt Cancer Center Tampa, Florida, United States

Piedmont Healthcare Atlanta, Georgia, United States

View all 21 locations

View Trial Details